David J Shapiro received his Ph.D. from Purdue University, did postdoctoral work at Stanford University School of Medicine and was a Guggenheim Fellow in the Center for Cancer research at MIT. He is the author of more than 100 research papers and book chapters in the field of steroid hormone receptor action and has served on the Editorial Boards of the Journal of Biological Chemistry (JBC), Molecular Endocrinology and other journals. Most current research focuses on identification and characterization of novel steroid receptor biomodulators; using biomodulators to identify previously undescribed pathways and evaluating them as anticancer drugs. David J Shapiro received his Ph.D. from Purdue University, did postdoctoral work at Stanford University School of Medicine and was a Guggenheim Fellow in the Center for Cancer research at MIT. He is the author of more than 100 research papers and book chapters in the field of steroid hormone receptor action and has served on the Editorial Boards of the Journal of Biological Chemistry (JBC), Molecular Endocrinology and other journals. Most current research focuses on identification and characterization of novel steroid receptor biomodulators; using biomodulators to identify previously undescribed pathways and evaluating them as anticancer drugs.

identification and characterization of novel steroid receptor biomodulators; using biomodulators to identify previously undescribed pathways and evaluating them as anticancer drugs.